Septic arthritis




This article presents a review of the current approach to diagnostic and therapeutic conditions of septic arthritis. Acute septic arthritis is an uncommon, but potentially fatal, emergency. Early diagnosis as well as prompt and effective treatment are essential to avoid either irreversible joint destruction or even death. The clinical features of this condition are different in neonates, children and adults. The definitive diagnosis of septic arthritis requires the direct demonstration of bacteria in synovial fluid or on positive culture of the pathogen. A combination of antibiotics and the prompt removal of purulent material from the affected joint constitutes the mainstay of successful treatment. In addition, this article discusses, in particular, prosthetic joint infection and gonococcal arthritis.


Infections of bones and/or joints are uncommon, but potentially fatal, emergencies that are associated with significant mortality and morbidity. Delayed or inadequate treatment can result in irreversible joint destruction, and the case-fatality rate is estimated to be approximately 11% . Therefore, early diagnosis as well as prompt and effective treatment are essential for avoiding severe outcomes. However, septic arthritis may be difficult to diagnose in certain situations and in certain populations, such as among children and the elderly.


In spite of advances in diagnostic techniques (particularly in the field of imaging) and the emergence of new antibiotics, the incidence of septic arthritis appears to have been increasing over the last few years. The ageing of the population, the widespread use of more potent immunosuppressant therapies and growing resistance to conventional antibiotics are among the major causes of this increase.


Epidemiology


Information concerning the epidemiology of septic arthritis is limited because of several factors. Acute septic arthritis is an uncommon disease; therefore, few reports of series containing more than 50 cases have been published, and most of the published reports are from retrospective cohorts . Moreover, the case definitions employed have, in general, restricted these studies to the investigation of bacteriologically confirmed cases.


The overall estimated incidence of septic arthritis in industrialised countries ranges from 2 to 6 cases per 100,000 person-years in the general population . In particular, the reported incidence of septic arthritis in Western Europe varies from 4 to 10 cases per 100,000 patient-years in the general population . Moreover, the incidence increases in populations with low socioeconomic status, as has been demonstrated by studies conducted in both Northern Europe and Australia . In Australia, the prevalence is reported to be 29 cases per 100,000 patient-years in the aboriginal population, with a relative risk of 6.6 in comparison with the Australian population in the Northern Territory .


Although individuals of all ages can be affected, septic arthritis is more prevalent in children and the elderly, and males are more frequently affected than females . In children, the incidence ranges from 5 to 12 cases per 100,000 person-years . Approximately one-third of the patients with septic arthritis are children younger than 2 years of age, and the disease has a lower incidence in patients younger than 3 months.


Mortality due to septic arthritis in hospitalised patients is reported to be approximately 2–10% of the total mortality in general hospitals in the United States of America .


In recent years, the incidence of septic arthritis has appeared to increase. Several factors may have contributed to this increase, including increased orthopaedic-procedure-related infections, an ageing population and an increase in the use of immunosuppressive therapy .

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Nov 11, 2017 | Posted by in RHEUMATOLOGY | Comments Off on Septic arthritis

Full access? Get Clinical Tree

Get Clinical Tree app for offline access